| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/27/2003 | US20030038826 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2003 | US20030038630 Method and device for the in situ detection of the degree of conversion of a non-magnetic phase in a ferromagnetic phase of a metallic work piece |
| 02/27/2003 | US20030038367 Semiconductor device and method for manufacturing the same |
| 02/27/2003 | US20030038198 Ball mill |
| 02/27/2003 | US20030038071 System and method for manipulating magnetically responsive particles in fluid samples to collect DNA or RNA from a sample |
| 02/27/2003 | US20030037620 High throughput mechanical rapid serial property testing of materials libraries |
| 02/27/2003 | US20030037603 Process for determining the distillation characteristics of liquid petroleum products by express mini-distillation and apparatus permitting implementation of this process |
| 02/27/2003 | US20030037602 Variable depth automated dynamic water profiler |
| 02/27/2003 | US20030037601 High throughput rheological testing of materials |
| 02/27/2003 | US20030037595 Non-destructive joint sealant testing device |
| 02/27/2003 | US20030037594 Method and system for determining the type of fuel used to power a vehicle |
| 02/27/2003 | US20030037593 Gas sensors and the manufacturing method thereof |
| 02/27/2003 | US20030037590 Method of self-testing a semiconductor chemical gas sensor including an embedded temperature sensor |
| 02/27/2003 | US20030037531 Yarn monitoring |
| 02/27/2003 | DE20212026U1 Building material hardness depth profile probe is handheld and has indicator strip |
| 02/27/2003 | CA2776899A1 In-situ adapter for a testing device |
| 02/27/2003 | CA2759776A1 In-situ adapter for a testing device |
| 02/27/2003 | CA2497343A1 Systems and methods for screening pharmaceutical chemicals |
| 02/27/2003 | CA2458890A1 Recombinant anti-plasmodium falciparum antibodies |
| 02/27/2003 | CA2458648A1 Secreted proteins |
| 02/27/2003 | CA2458643A1 Nucleic-acid associated proteins |
| 02/27/2003 | CA2458625A1 Transporters and ion channels |
| 02/27/2003 | CA2458193A1 Development of transgenic model for interventions in neurodegenerative diseases |
| 02/27/2003 | CA2457932A1 Sodium channel regulators and modulators |
| 02/27/2003 | CA2457918A1 Mullerian inhibiting substance levels and ovarian response |
| 02/27/2003 | CA2457823A1 Methods for diagnosing and treating neoplasias using nf-at transcription factors |
| 02/27/2003 | CA2457799A1 Method and quantification assay for determining c-kit/scf/pakt status |
| 02/27/2003 | CA2457789A1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 02/27/2003 | CA2457783A1 Oligonucleotide compositions and their use to induce apoptosis |
| 02/27/2003 | CA2457775A1 Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| 02/27/2003 | CA2457695A1 Absolute quantification of proteins and modified forms thereof by multistage mass spectrometry |
| 02/27/2003 | CA2457632A1 Identification and isolation of somatic stem cells and uses thereof |
| 02/27/2003 | CA2457461A1 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c5b |
| 02/27/2003 | CA2457432A1 Method and system for profiling biological systems |
| 02/27/2003 | CA2457405A1 Compositions and methods relating to benzodiazepine compounds |
| 02/27/2003 | CA2457370A1 Age-associated markers |
| 02/27/2003 | CA2457365A1 Polymorphisms associated with ion-channel disease |
| 02/27/2003 | CA2457317A1 Transgenic rodents as animal models for modulation of b1 bradykinin receptor protein |
| 02/27/2003 | CA2457065A1 Periostin-based diagnostic assays |
| 02/27/2003 | CA2457043A1 Medicinal use of histone deacetylase inhibitor and method of evaluating antitumor effect thereof |
| 02/27/2003 | CA2456470A1 Interleukin-2 mutants with reduced toxicity |
| 02/27/2003 | CA2456340A1 Propagation of human hepatoblastoma cell in non-human animals |
| 02/27/2003 | CA2456334A1 Molecular characteristics of non-small cell lung cancer |
| 02/27/2003 | CA2456290A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides |
| 02/27/2003 | CA2455793A1 Method and apparatus for rapid determination of ligand-protein binding using charcoal adsorption |
| 02/27/2003 | CA2454879A1 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 02/27/2003 | CA2454756A1 Methods and compounds for the targeting of protein to exosomes |
| 02/27/2003 | CA2451998A1 Anti-a.beta. antibodies |
| 02/27/2003 | CA2443532A1 Measurement of microbiological activity in an opaque medium |
| 02/27/2003 | CA2436426A1 Anti-ciguatoxin monoclonal antibody |
| 02/26/2003 | WO2002018407A2 Antisense oligonucleotides against vanilloid receptor 1 |
| 02/26/2003 | EP1286165A2 Neuropeptide receptor and uses thereof |
| 02/26/2003 | EP1286164A2 Methods and apparatus for improved luminescence assays |
| 02/26/2003 | EP1286163A2 Evaluation of agents for treatment of Schizophrenia |
| 02/26/2003 | EP1286162A2 Blood glucose sensor dispensing instrument having a pull/push activation mechanism |
| 02/26/2003 | EP1286161A2 Device for assessing motor oil quality and an apparatus and method for testing engine or exhaust-gas using the same |
| 02/26/2003 | EP1286155A1 Gas detector and automobile ventilation system |
| 02/26/2003 | EP1286153A1 Method and apparatus for identifying plastic |
| 02/26/2003 | EP1285970A2 Metastasis-associated genes |
| 02/26/2003 | EP1285961A1 Method of forming vertebrate pancreas in vitro |
| 02/26/2003 | EP1285960A2 Virulence genes from Salmonella typhimurium |
| 02/26/2003 | EP1285930A2 Human antibodies that bind human TNFalpha |
| 02/26/2003 | EP1285695A2 Packaging system for test sensors |
| 02/26/2003 | EP1285390A2 Method and system for the assembly of a whole genome using a shot-gun data set |
| 02/26/2003 | EP1285301A1 Device for sequential observation of samples and methods using same |
| 02/26/2003 | EP1285290A1 Micro-array evanescent wave fluorescence detection device |
| 02/26/2003 | EP1285273A1 Il-6 detection for predicting risks of preterm delivery |
| 02/26/2003 | EP1285272A2 Compositions and methods for screening therapeutic agents |
| 02/26/2003 | EP1285271A2 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen |
| 02/26/2003 | EP1285270A2 Method for identifying compounds for modulating the activity of a tumour suppressor protein |
| 02/26/2003 | EP1285269A2 Lipid uptake assays |
| 02/26/2003 | EP1285268A1 Detection system for sorting apparatus |
| 02/26/2003 | EP1285267A2 Emission sampling apparatus and method |
| 02/26/2003 | EP1285266A1 Method and device for measuring a component in a liquid sample |
| 02/26/2003 | EP1285261A1 Field effect transistor device for ultra-fast nucleic acid sequencing |
| 02/26/2003 | EP1285258A2 Gas sensors with improved resistance to humidity interference |
| 02/26/2003 | EP1285257A2 Processing chamber with apertures for pipette access |
| 02/26/2003 | EP1285252A1 An ultra-fast nucleic acid sequencing device and a method for making and using the same |
| 02/26/2003 | EP1285251A1 Sample cylinder, especially a sample cylinder that is provided with a filtration device for recovering cell material from body fluids |
| 02/26/2003 | EP1285244A1 Apparatus and method for measuring and correlating characteristics of fruit with visible/near infra-red spectrum |
| 02/26/2003 | EP1285114A1 Methods for analyzing boron-containing alkaline pulping liquors |
| 02/26/2003 | EP1285093A2 Single copy genomic hybridization probes and method of generating same |
| 02/26/2003 | EP1285092A2 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 02/26/2003 | EP1285090A1 Detection of nucleotide sequence variations via the proofreading activity of polymerases |
| 02/26/2003 | EP1285089A1 Methods for monitoring the expression of alternatively spliced genes |
| 02/26/2003 | EP1285087A2 Enzymatic assays for screening anti-cancer agents |
| 02/26/2003 | EP1285074A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/26/2003 | EP1285071A2 Novel dual oxidases as mitogenic and endocrine regulators |
| 02/26/2003 | EP1285068A2 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 02/26/2003 | EP1285066A1 F-box containing protein |
| 02/26/2003 | EP1285065A2 Long wavelength engineered fluorescent proteins |
| 02/26/2003 | EP1285058A2 Fertilization of aged oocytes |
| 02/26/2003 | EP1285003A1 Use of a secondary cell wall polymer of procaryotic microorganisms |
| 02/26/2003 | EP1285002A2 REGULATING LIPID LEVELS VIA THE i ZMAX1 /i OR i HBM /i GENE |
| 02/26/2003 | EP1285001A1 Methods for identifying modulators of the interaction between lap (latency associated peptide) and integrin alpha.v.beta.3 and medical use thereof |
| 02/26/2003 | EP1284993A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella paraperussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions |
| 02/26/2003 | EP1284989A1 Separation of avian antibodies |
| 02/26/2003 | EP1284952A1 Substituted chalcones as therapeutic compounds |
| 02/26/2003 | EP1284929A1 Autocycle control of cooling water systems |
| 02/26/2003 | EP1284729A1 A(beta)42 lowering agents |